The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|7|1009-1009

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.7, 2015-06, pp. : 1009-1009

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicergoline in Mild to Moderate Dementia: A Multicenter, Double‐Blind, Placebo‐Controlled Study

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 37, Iss. 4, 1989-04 ,pp. : 295-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 329-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 1351-5101, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

TALOS: a multicenter, randomized, double‐blind, placebo‐controlled trial to test the effects of citalopram in patients with acute stroke

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 985-987

John Wiley & Sons Inc

Access to resources Recommend Favorite